Search Results 861-870 of 21575 for Inhibition

1. A Study to Evaluate Tazemetostat and Pembrolizumab to Treat Advanced Urothelial Carcinoma - Mayo Clinic

   For this reason and because PD-1 inhibitors as well as EZH2 inhibitors are ... Patients who have received prior PD-L1/PD-1/PD-L2 or EZH2 inhibitor therapy are not ...

2. Publications - Elisabeth I. Heath, M.D. - Mayo Clinic

   Inhibition of PIM kinase in tumor-associated macrophages suppresses inflammasome activation and sensitizes prostate cancer to immunotherapy. Cancer Immunol ...

3. Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease - Mayo Clinic

   ... inhibitors or inducers of CYP3A4 (e.g., cyclosporine, tacrolimus or sirolimus). Tyrosine kinase inhibitor therapy. Subjects on therapeutic doses of ...

4. A Study to Evaluate Exemestane in Post-Menopausal Women with Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

   ... inhibitor (pembrolizumab, atezolizumab, or nivolumab). NOTE: Pathology reports documenting the diagnosis of NSCLC are required to be reviewed to confirm ...

5. Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome - Mayo Clinic

   High dose corticosteroids, immune modulatory drugs (thalidomide or lenalidomide), or proteosome inhibitors (e.g. ixazomib or bortezomib) ≤ 28 days prior to ...

6. Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients with Relapsed or Relapsed/Refractory Multiple Myeloma - Mayo Clinic

   Patients must have had therapy with a proteasome inhibitor and ... inhibitors of cytochrome P450, family 3, subfamily A (CYP3A) (clarithromycin ...

7. Amylase/lipase/pancrelipase/protease (oral route) - Side effects & dosage - Mayo Clinic

   Viokace™ tablet is used in combination with certain medicines for stomach ulcer called proton pump inhibitors (eg, esomeprazole, lansoprazole, omeprazole, ...

8. A Study of Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure that has Preserved Ejection Fraction - Mayo Clinic

   No daily use of phosphodiesterase 5 (PDE5) inhibitors ... Ongoing requirement for PDE5 inhibitor, organic nitrate or soluble guanylyl cyclase activators.

9. Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors - Mayo Clinic

   Chronic concomitant treatment with strong inhibitors or inducers of CYP3A4 is not allowed on this study. Patients on strong inhibitors or inducers of CYP3A4 ...

10. Secondary hypertension - Diagnosis & treatment - Mayo Clinic

    Like ACE inhibitors, angiotensin II receptor blockers often are useful for people with coronary artery disease, heart failure or kidney failure. These ...